![Frank Gentile](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Gentile
Founder at
Casma Therapeutics, Inc.
Profile
Dr. Frank T.
Gentile is a Chief Executive Officer & Director at Casma Therapeutics, Inc. He is on the Board of Directors at Casma Therapeutics, Inc. and Raven Biotechnologies, Inc.
Dr. Gentile was previously employed as a Venture Partner by Third Rock Ventures LLC, a Senior Vice President by Tekla Capital Management LLC, a Vice President-Technology Program Management by Takeda Oncology Co., a Research Analyst by Millennium TVP Management Co. LLC, a Vice President-Program Management by Reprogenesis, Inc., a Vice President-Product Development by Curis, Inc., and a Principal by CytoTherapuetics, Inc. He also served on the board at FlowCardia, Inc., CardioKinetix, Inc., Conor Medsystems LLC, Euthymics Bioscience, Inc., Insightra Medical, Inc., Neurovance, Inc. and Veniti, Inc.
He received his undergraduate degree from the The Cooper Union for the Advancement of Science & Art and a doctorate degree from Massachusetts Institute of Technology.
Frank Gentile active positions
| Companies | Position | Start |
|---|---|---|
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Director/Board Member | - |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates MA-based biotechnology company harnessing natural cellular process of autophagy to design new medicines | Founder | 2018-04-30 |
Former positions of Frank Gentile
| Companies | Position | End |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 2018-09-30 |
Conor Medsystems LLC
 Conor Medsystems LLC Medical SpecialtiesHealth Technology Develops vascular drug delivery technologies | Director/Board Member | 2005-03-22 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 2001-12-30 |
Millennium TVP Management Co. LLC
 Millennium TVP Management Co. LLC Investment ManagersFinance Millennium TVP invests in companies located in the United States. The firm targets companies operating in the technology sector such as AI/ML, infrastructure, logistics, energy, manufacturing, and developer productivity. It provides both equity and debt financing for early to growth stage, special situations, and secondary transactions. | Private Equity Analyst | 2001-06-29 |
| CURIS, INC. | Corporate Officer/Principal | 2001-01-31 |
Training of Frank Gentile
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Develops vascular drug delivery technologies | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Commercial Services |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Produces products in urology, cardiovascular biology, plastic, and reconstructive surgery | Health Technology |
Millennium TVP Management Co. LLC
Millennium TVP Management Co. LLC Investment ManagersFinance Millennium TVP invests in companies located in the United States. The firm targets companies operating in the technology sector such as AI/ML, infrastructure, logistics, energy, manufacturing, and developer productivity. It provides both equity and debt financing for early to growth stage, special situations, and secondary transactions. | Finance |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures endovascular devices | Health Technology |
The Cooper Union for the Advancement of Science & Art
 The Cooper Union for the Advancement of Science & Art Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology Develops ventricular partitioning device for heart failure disease | Health Technology |
Insightra Medical, Inc.
 Insightra Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel medicine for alcohol use disorder (AUD) and smoking cessation | Commercial Services |
Veniti, Inc.
 Veniti, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses on the treatment of venous insufficiency | Health Technology |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates MA-based biotechnology company harnessing natural cellular process of autophagy to design new medicines | Commercial Services |
- Stock Market
- Insiders
- Frank Gentile
